A new study published in the science journal PLOS One has found that activation of the body’s cannabinoid receptors – something which cannabis does naturally – is directly linked to a reduction in the pain associated with Devic’s syndrome, a rare form of multiple sclerosis.
The study, which was funded in part by the German Research Foundation, the German Federal Ministry of Education and Research and the German Research Network on Neuropathic Pain, found that; “Consequently, increasing plasma levels of 2-AG [a cannabinoid receptor] mitigate mechanical pain sensitivity, while an absence of 2-AG increase leaves these NMO [neuromyelitis optica] patients with full-blown hyperalgesia.”
The study was conducted by researchers at Ludwig-Maximilians University, Georg August University and the University Heidelberg.
A recently study published online by the journal Neurobiology of Disease (and being published in print in their November edition) also found that cannabis can be beneficial to multiple sclerosis; researchers concluded that cannabidiol – a compound found in cannabis – can provide “long-lasting protection” against multiple sclerosis.
The study can be found here: http://www.plosone.org/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0071500;jsessionid=34A41E2B6D62AF1CC16A6E62998F2B63